A monthly dividend is a marketing decision, not a margin of safety
It traded at 54.30, -1.30% on the session. Payment frequency tells you nothing about whether the payment is funded.
It traded at 54.30, -1.30% on the session. Payment frequency tells you nothing about whether the payment is funded.
It traded at 35.52, -0.84% today. Moving from wholesale to direct raises margin and burns the shelf space it took decades to earn.
It traded at 334.88, -0.41% today. The largest banks are not better lenders. They borrow more cheaply, and that is enough.
It traded at 607.67, -1.27% on the session. Being the credible alternative is worth a great deal to customers and less than people assume to shareholders.
It traded at 188.62, -1.74% on the session. A multi-year order book tells you what is coming. It does not tell you at what margin.
It traded at 399.54, +0.71% today. The interesting economics in med-tech are not in selling the machine.
The index traded at 206.55, -1.99% on the session. Biotech is the one sector where position sizing matters more than being right.
It traded at 32.72, +0.52% today. Same store sales growth built on price rather than footfall has a shelf life.
It traded at 31.39, -0.14% on the session. An income investment is a claim on cash, and everything else is commentary.
It traded at 250.05, +0.53% today. The idea that security budgets never get cut has not actually been tested in a proper downturn.
It traded at 137.01, -3.12% on the session. When a company changes how it counts its most important metric, that is the story.
It traded at 1747.95, +3.05% today. A supplier with no substitute is a wonderful business and a concentrated risk at the same time.
It traded at 736.60, +0.70% on the session. A healthy core funding an expensive bet is the hardest situation to value honestly.
The shares traded at 498.00, -1.80% today. Enormous capital spending has been treated as a growth signal. It is also a cost that arrives later, on a schedule.
The shares traded at 368.86, -0.74% today. The interchange debate is real, recurring, and has not yet changed the shape of the business.
The shares traded at 138.49, +1.13% today. Long leases look like safety until you ask what they are priced against.
The stock traded at 910.51, -0.32% on the session. The interesting question about a membership retailer is never the margin on what they sell.
Regionals traded at 75.26, +0.98% on the session. Funding costs are the whole story and they are the part least discussed.
Memory traded at 1014.74, +4.46% today. Every cycle, the story is that this time capacity discipline holds. It has not yet.
Reopen regression body with a heading list and blank lines. Second paragraph after several blank lines.
First section with plenty of characters here. Second section far below.
A body about a chart that will be deleted before publishing, well past twenty characters.
Twenty characters of body text minimum for the zod floor, typed and published inside the autosave window.
A short chart walkthrough of the MSFT levels that matter today.
How I value the systems business separately from the chips inside it.
Every mega-cap has spent heavily on AI capacity. The market is now asking one thing: when does the spending start returning cash.
Every drop in the cost of running a model makes new uses economic. The cloud that rents the capacity gains from the volume, whoever makes the model.
The AI-native customer growth I track, and how it shows up in usage.
The three layers I value separately, and why together they are worth more.
When rates fall, lending margins compress. The fee businesses of a large bank move on different drivers entirely.